A lack of understanding about what scabies is and how it’s treated could be behind the United Kingdom’s sudden spike in cases ...
The two-time U.S. Olympic gold medalist gymnast opens up about her skin condition, her fashion dos and don’ts for eczema, and ...
Sanofi has reported mixed phase 3 data on amlitelimab, further muddying the prospec | Sanofi has reported mixed phase 3 data ...
Onlymyhealth on MSN
Persistent Itching In Legs? This May Be An Early Sign Of Vein Problem
Are you experiencing constant itchiness in your legs? If you feel this is a harmless skin rash or allergy, then think again. Itchy skin in the legs may indicate a much more serious condition. There ...
Nearly 9 in 10 adults and parents of children with plaque psoriasis, atopic dermatitis, and seborrheic dermatitis being ...
Millions of Brits with eczema are almost twice as likely to suffer agonising eye and bowel conditions, research suggests.
Fresh data from multiple studies suggest the drug, which Sanofi has billed as a future blockbuster, could be cleared in the U ...
Corvus Pharma (CRVS) stock surges as the company plans a Phase 2 trial for its lead asset against eczema following ...
We recently published 10 Stocks With Effortless Double-, Triple-Digit Gains. Corvus Pharmaceuticals Inc. (NASDAQ:CRVS) was ...
Analyzing patient health care notes recorded during millions of medical appointments at GPs and hospitals across England has ...
Corvus Pharma reports encouraging data for its eczema drug soquelitinib, showing strong skin improvement and no serious ...
Amlitelimab, an OX40 ligand–targeting therapy that modulates T-cell-mediated inflammation without causing cell depletion, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results